1 |
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium.
|
|
|
|
In: Alzheimer's & dementia : the journal of the Alzheimer's Association, vol 16, iss 1 (2020)
|
|
BASE
|
|
Show details
|
|
2 |
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium.
|
|
|
|
In: Alzheimer's & dementia : the journal of the Alzheimer's Association, vol 16, iss 1 (2020)
|
|
BASE
|
|
Show details
|
|
3 |
C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts.
|
|
|
|
In: Neurology, vol 95, iss 24 (2020)
|
|
BASE
|
|
Show details
|
|
4 |
C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts
|
|
|
|
BASE
|
|
Show details
|
|
5 |
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium
|
|
|
|
In: Alzheimers Dement (2020)
|
|
BASE
|
|
Show details
|
|
6 |
C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts
|
|
|
|
In: Neurology (2020)
|
|
BASE
|
|
Show details
|
|
7 |
C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts
|
|
|
|
BASE
|
|
Show details
|
|
8 |
Longitudinal progression of grey matter atrophy in non-amnestic Alzheimer’s disease
|
|
|
|
In: Brain (2019)
|
|
BASE
|
|
Show details
|
|
9 |
Clinical marker for Alzheimer disease pathology in logopenic primary progressive aphasia
|
|
|
|
BASE
|
|
Show details
|
|
10 |
Typical and atypical pathology in primary progressive aphasia variants
|
|
|
|
BASE
|
|
Show details
|
|
11 |
Neocortical Origin and Progression of Grey Matter Atrophy In Non-Amnestic Alzheimer’s Disease
|
|
|
|
BASE
|
|
Show details
|
|
12 |
Large-scale Exploratory Genetic Analysis of Cognitive Impairment in Parkinson’s Disease
|
|
|
|
BASE
|
|
Show details
|
|
13 |
Cross-sectional and longitudinal features of non-fluent/agrammatic primary progressive aphasia with underlying corticobasal degeneration or progressive supranuclear palsy pathology
|
|
|
|
BASE
|
|
Show details
|
|
14 |
In vivo signatures of nonfluent/agrammatic primary progressive aphasia caused by FTLD pathology
|
|
|
|
BASE
|
|
Show details
|
|
16 |
Frequency and Clinicopathological Characteristics of Presenilin 1 Gly206Ala Mutation in Puerto Rican Hispanics with Dementia
|
|
|
|
BASE
|
|
Show details
|
|
17 |
DISRUPTION OF LARGE-SCALE NEURAL NETWORKS IN NON-FLUENT/AGRAMMATIC VARIANT PRIMARY PROGRESSIVE APHASIA ASSOCIATED WITH FRONTOTEMPORAL DEGENERATION PATHOLOGY
|
|
|
|
BASE
|
|
Show details
|
|
18 |
Biomarkers in Frontotemporal Lobar Degenerations – Progress and Challenges
|
|
|
|
BASE
|
|
Show details
|
|
19 |
Behavioral-variant frontotemporal dementia with corticobasal degeneration pathology: Phenotypic comparison to bvFTD with Pick’s disease
|
|
|
|
BASE
|
|
Show details
|
|
|
|